BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5955773)

  • 1. Carcinoma of the cervix. Automated methods for cancer screening.
    Husain OA; Cameron CB
    Proc R Soc Med; 1966 Oct; 59(10):982-6. PubMed ID: 5955773
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for cervical cancer.
    Br Med J; 1967 Jun; 2(5555):782-3. PubMed ID: 6029136
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical modifications of the 6-phosphogluconate dehydrogenase test of the vaginal fluid.
    Sanner T; Bergsjo P; Koller O; Kolstad P; Pihl A
    Am J Obstet Gynecol; 1967 Jul; 98(6):800-3. PubMed ID: 6027708
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical screening for carcinoma: a comparison of cytological and enzyme (6-phosphogluconate dehydrogenase) methods and clinical findings.
    Boyd JT; Gibbs DF; Labrum AH; Philps FR
    Br Med J; 1967 Jun; 2(5555):785-92. PubMed ID: 6029138
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-phosphogluconate dehydrogenase (6PGD) activity in the cervical mucus and vaginal fluid in benign and malignant gynaecological lesions.
    Brooks PC; Muir GG
    J Obstet Gynaecol Br Commonw; 1967 Feb; 74(1):111-4. PubMed ID: 6018084
    [No Abstract]   [Full Text] [Related]  

  • 6. The alleged usefulness of 6-phosphogluconate dehydrogenase determinations in screening for uterine cancer.
    Sanner T; Bentzen H; Kolstad P; Nordbye K; Pihl A
    Acta Obstet Gynecol Scand; 1970; 49(4):371-4. PubMed ID: 5519624
    [No Abstract]   [Full Text] [Related]  

  • 7. The source of 6-phosphogluconate dehydrogenase in vaginal fluid samples.
    Churchouse MJ; Carter GN; Bonham DG
    J Obstet Gynaecol Br Commonw; 1967 Oct; 74(5):712-22. PubMed ID: 6058534
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic test for cervical cancer.
    Goldberg DM; Watts C; Hart DM
    Br Med J; 1968 Feb; 1(5589):424-5. PubMed ID: 5639628
    [No Abstract]   [Full Text] [Related]  

  • 9. LABORATORY DIAGNOSIS OF EARLY MALIGNANT DISEASE. NEW DIAGNOSTIC TESTS FOR CANCER OF THE UTERUS.
    BONHAM DG
    Trans Med Soc Lond; 1964; 80():30-41. PubMed ID: 14270933
    [No Abstract]   [Full Text] [Related]  

  • 10. A NEW TEST FOR THE DIAGNOSIS OF GYNAECOLOGICAL CANCER, 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID.
    BONHAM DG
    Triangle; 1964 Jan; 7():157-62. PubMed ID: 14154689
    [No Abstract]   [Full Text] [Related]  

  • 11. [Colour contact enzymatic test in prevention of uterine cervix cancer (author's transl)].
    Kanka J; Marsíková L; Svoboda B; Kinst L; Kolin J; Reisenauer R
    Cesk Gynekol; 1977 Mar; 42(2):102-6. PubMed ID: 852014
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of blood on the assay of 6-phosphogluconate dehydrogenase in vaginal fluid.
    Gibbs DF
    J Clin Pathol; 1968 Mar; 21(2):189-91. PubMed ID: 4235156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of preinvasive and early invasive cancer by 6-phosphogluconate dehydrogenase determinations.
    Kolstad P; Bergsjo P; Koller O; Pihl A; Sanner T
    Am J Obstet Gynecol; 1967 Jul; 98(6):804-7. PubMed ID: 6027709
    [No Abstract]   [Full Text] [Related]  

  • 14. A new enzyme test for gynaecological cancer. 6-Phosphogluconate dehydrogenase activity in vaginal fluid.
    BONHAM DG; GIBBS DF
    Br Med J; 1962 Sep; 2(5308):823-4. PubMed ID: 13870993
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of 6-PGDH in the vaginal secretions of patients with carcinoma of the cervix. A new method of collection of vaginal secretions.
    Hasch E; Sorensen B; Laursen T
    Acta Obstet Gynecol Scand; 1971; 50(1):37-9. PubMed ID: 5558596
    [No Abstract]   [Full Text] [Related]  

  • 16. Histochemical demonstration of pentose shunt activity in smears from the uterine cervix.
    Cohen S; Way S
    Br Med J; 1966 Jan; 1(5479):88-9. PubMed ID: 5902532
    [No Abstract]   [Full Text] [Related]  

  • 17. 6-PHOSPHOGLUCONATE DEHYDROGENASE ESTIMATION IN VAGINAL FLUID IN THE DIAGNOSIS OF CERVICAL CANCER.
    BELL JL; EGERTON ME
    J Obstet Gynaecol Br Commonw; 1965 Aug; 72():603-9. PubMed ID: 14341115
    [No Abstract]   [Full Text] [Related]  

  • 18. [Impulse cytophotometric measurements on atypical cell smears from vagina and cervix uteri].
    Göhde W; Dittrich W; Zinser KH; Prieshof J
    Geburtshilfe Frauenheilkd; 1972 May; 32(5):382-93. PubMed ID: 4558244
    [No Abstract]   [Full Text] [Related]  

  • 19. 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID: LIMITATIONS AS A SCREENING TEST FOR GENITAL CANCER.
    CAMERON CB; HUSAIN OA
    Br Med J; 1965 Jun; 1(5449):1529-30. PubMed ID: 14288104
    [No Abstract]   [Full Text] [Related]  

  • 20. Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.
    Messelt OT; Höeg K
    Acta Cytol; 1967; 11(1):39-40. PubMed ID: 5230439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.